MARKET NEWS

Palvella Therapeutics Announces Closing of Merger With Pieris Pharmaceuticals & Concurrent Private Placement of $78.9 Million
Verge Genomics Announces New Development Candidate, a Novel Maintenance Therapy for Long-Term Weight Management
Innoviva Specialty Therapeutics Signs Exclusive Distribution & Licensing Agreement
Atsena Therapeutics Announces Dosing Completed in Part A of Phase 1/2 Clinical Trial Evaluating Gene Therapy to Treat X-linked Retinoschisis
HUTCHMED to Receive Milestone Payment From Takeda
Assertio Announces Results of Rolvedon Injection Same-Day Dosing Clinical Study
VelaLabs Announces Strategic Partnership to Support Biological Drugs Development
Conduit Pharmaceuticals to Revolutionize Drug Development Through Agreement to Use AI & Cybernetics
Immuneering Granted FDA Fast Track Designation for IMM-1-104 in Advanced Melanoma
PDC*line Pharma Presents Primary Clinical Results From Phase I/II Trial on PDC*lung01 Cancer Vaccine

  EXPERT CONTENT & RESOURCES

3 Key Things to Consider When Choosing a Partner for Your Tech Transfer

3 Key Things to Consider When Choosing a Partner for Your Tech Transfer

One way of streamlining tech transfer is to partner with a CMO demonstrating a proven track record across the entire drug development and manufacturing continuum. Not only will an experienced CMO partner have the scientific….

CLINICAL TRIALS - Need for Accessibility to Meet FDA Guidance for Decentralized Trials

CLINICAL TRIALS - Need for Accessibility to Meet FDA Guidance for Decentralized Trials

Neil Vivian believes advances in electronic data collection and analysis are helping to make DCTs more accessible to broader and more diverse patient populations. Further innovations, particularly in artificial intelligence technology, are expected to accelerate these trends.  

  FEATURED EDITORIAL

  COMPANY PROFILE

Woodstock Sterile Solutions is a global provider of best-in-class sterile development and manufacturing solutions – with a decades-long track record of helping healthcare companies advance molecules through clinical development into full-scale commercial production. Throughout our 50-year history, Woodstock has been a leader in developing and deploying advanced aseptic blow-fill-seal delivery products. Today, Woodstock Sterile Solutions is a reliable partner in the development of complex, high-quality sterile products from ophthalmic and respiratory therapeutics to diagnostics and complex orals. Our experience with formulation and the development cycle is a core strength. Woodstock Sterile Solutions is at its best with complex solutions, suspensions, and emulsions, as well as biologics, sterile products, potent compounds, and sensitive APIs. Click here for more.

  WHITEPAPERS & WEBINARS

WEBINAR: Introducing Key Concepts in Tableting Research: Unleashing Essential Concepts and Strategies for Enhanced Formulation Development

WEBINAR: Introducing Key Concepts in Tableting Research: Unleashing Essential Concepts and Strategies for Enhanced Formulation Development

Tableting can present a series of challenges, particularly when dealing with formulations that have poor flowability, low compressibility, or high cohesivity. These issues can lead to manufacturing inefficiencies….

  WHITEPAPERS & WEBINARS

ARTICLE - A New Framework for Identifying Nitrosamine Risks & Efficiently Derisking Products

ARTICLE - A New Framework for Identifying Nitrosamine Risks & Efficiently Derisking Products

A clear standard for identifying APIs susceptible to Nitrosamine Drug Substance-Related Impurities (NDSRI) formation has been elusive—until now. Adare’s team of nitrosamine experts have developed a straightforward framework that simplifies the identification of at-risk APIs. Discover how this innovative approach …

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Technical Brief: Mucoadhesive Polymers in Pharmaceutical Formulations

Mucoadhesion Matters

And so does your choice of mucoadhesive polymer.

This technical brief will cover the use of polymers in a variety of dosage forms (buccal/sublingual tablets, liquid, semi-solid formulations, and oral care products) to impart mucoadhesion. The basic mechanism …

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

WHITEPAPER - Unlock the Secrets of Spray Drying for Sticky APIs

It is widely reported that 40% of New Chemical Entities (NCEs) in the pharmaceutical industry are poorly soluble, leading to inadequate bioavailablity. Spray drying is one of the most promising particle engineering technologies used to overcome solubility issues in active …

CASE STUDY - Overcoming Barriers to Patient Adherence With A Novel Dosage Form

CASE STUDY - Overcoming Barriers to Patient Adherence With A Novel Dosage Form

When a mid-sized pharmaceutical company asked Adare to make a version of their drug that was more convenient for patients with tremors or swallowing difficulties, our experts created a sprinkle formulation of the drug. In this CPHI Award-winning case study, …

  DRUG DEVELOPMENT DIRECT RESOURCES

Upcoming eNewsletter Features:

January 8 – Capsules
January 15 – Excipients